http://www.youtube.com/watch?v=VwZWa76vKFE

http://www.youtube.com/watch?v=VwZWa76vKFE

Ranking

http://ontario.compareschoolrankings.org/elementary/SchoolsByAreaMap.aspx
http://ontario.compareschoolrankings.org/secondary/SchoolsByAreaMap.aspx

http://www.imuc.com/pdf/Griffin-Industry-Report-09-14-2009.pdf

http://www.imuc.com/pdf/Griffin-Industry-Report-09-14-2009.pdf

Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739007/


Breast CS CD44+/CD24-/Lin-
Prospective identification of tumorigenic breast cancer cells

BEZ235 vs CD44+

Combination Therapy Targeting Both Tumor-Initiating and Differentiated Cell Populations in Prostate Carcinoma

Results: Here, we show that inhibition of PI3K activity by the dual PI3K/mTOR inhibitor NVP-BEZ235 leads to a decrease in the population of CD133⁺/CD44⁺ prostate cancer progenitor cells in vivo. Moreover, the combination of the PI3K/mTOR modulator NVP-BEZ235, which eliminates prostate cancer progenitor populations, and the chemotherapeutic drug Taxotere, which targets the bulk tumor, is significantly more effective in eradicating tumors in a prostate cancer xenograft model than monotherapy.

Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening

http://www.cell.com/retrieve/pii/S0092867409007818

http://www.workingincanada.gc.ca/report-eng.do?action=display_allnoc

http://www.workingincanada.gc.ca/report-eng.do?action=display_allnoc

gene profiling of cancer stem cell

http://www.google.com/search?q=gene+profiling+of+cancer+stem+cell&rls=com.microsoft:en-US&ie=UTF-8&oe=UTF-8&startIndex=&startPage=0


http://www.molecular-cancer.com/content/6/1/75

http://genomebiology.com/content/9/5/R83